Nateglinide (Starlix®) is a drug for the treatment of type II diabetes.

Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs and is sold by Novartis.

Pharmacology

---

Nateglinide lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the beta cells. This depolarizes the beta cells, opening the cells' calcium channels, and the resulting calcium influx induces insulin secretion.

Dosage

---

Nateglinide is delivered in tablet form.

External links

---

• Starlix - website of the manufacturer.
• How Nateglinide Works - website of the manufacturer.

Diabetes Anti-diabetic drugs